Evidence map›Paper›PMID 41199255›Full record

ArticleBMC medical informatics and decision making2025

Treatment decision support for esophageal cancer based on PET/CT data using deep learning.

Qiuxiang Zheng, Fobao Lai, Zhiyong Chen

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiuxiang Zheng *Department of Oncology, Longyan First Affiliated Hospital of Fujian Medical University, 105 North Jiuyi Road, Longyan, Fujian, 364000, China.
Fobao Lai *Department of Oncology, Longyan First Affiliated Hospital of Fujian Medical University, 105 North Jiuyi Road, Longyan, Fujian, 364000, China.
Zhiyong ChenDepartment of Oncology, Longyan First Affiliated Hospital of Fujian Medical University, 105 North Jiuyi Road, Longyan, Fujian, 364000, China. czyong126@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaking precise treatment decisions in esophageal cancer is essential for enhancing patient outcomes and avoiding overtreatment. Traditional approaches relying on special features or shallow learning models often fail to capture the complex, multi-scale patterns embedded in PET/CT imaging data. Recent advances in deep learning provide an opportunity to build more robust, data-driven systems for predictive modeling in oncology.

methodsWe propose a novel deep learning model that integrates convolutional and transformer-based components based on PET/CT data to support treatment decisions for esophageal cancer. The architecture introduces a Convolutional Feature Extractor with split-based residual blocks for efficient local feature capture, a Multi-scale Pooling module for spatial context aggregation, and an Multilayer Perceptron block for predicting. The model was evaluated using several performance metrics such as AUCROC, F1 score, Balanced Accuracy and benchmarked against state-of-the-art convolutional and transformer backbones such as ConvNeXt and Vision Transformer.

resultsThe proposed model achieved superior performance across all evaluation metrics, including an AUCROC of 0.9935 and a Balanced Accuracy of 0.9630, outperforming existing models. These results validate the effectiveness of combining local-global representation learning through custom-designed modules. In addition, we conducted ablation studies to further demonstrate the individual contributions and effectiveness of each component within the proposed architecture. By systematically removing or replacing specific modules such as the Convolutional Feature Extractor and Multi-scale Pooling, we observed consistent performance degradation, which highlights the necessity and complementary roles of these components in achieving optimal predictive accuracy.

conclusionsThis study presents a novel hybrid deep learning architecture that enhances treatment decision support for esophageal cancer by leveraging multi-scale spatial encoding. The empirical evidence demonstrates that tailored architectural innovations significantly improve predictive accuracy over existing methods.

Indexed as

Decision Support Systems, ClinicalDeep LearningEsophageal NeoplasmsPositron Emission Tomography Computed TomographyHumansDeep learningEsophageal cancerPET/CT scan

Identifiers

PMID41199255
PMCPMC12593911

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.